Literature DB >> 16011536

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).

B Gazzard1.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16011536     DOI: 10.1111/j.1468-1293.2005.0311b.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  27 in total

Review 1.  A review of the use of complementary and alternative medicine and HIV: issues for patient care.

Authors:  Ava Lorenc; Nicola Robinson
Journal:  AIDS Patient Care STDS       Date:  2013-09       Impact factor: 5.078

2.  Cost effectiveness of darunavir/ritonavir 600/100 mg bid in protease inhibitor-experienced, HIV-1-infected adults in Belgium, Italy, Sweden and the UK.

Authors:  Karen Moeremans; Lieven Annemans; Mickael Löthgren; Gabriele Allegri; Veronique Wyffels; Lindsay Hemmet; Karin Caekelbergh; Erik Smets
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  Cost effectiveness of darunavir/ritonavir in highly treatment-experienced, HIV-1-infected adults in the USA.

Authors:  Josephine Mauskopf; Anita Brogan; Silas Martin; Erik Smets
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 4.  Antiretroviral treatment of HIV infected adults.

Authors:  Steven G Deeks
Journal:  BMJ       Date:  2006-06-24

Review 5.  When should antiretroviral therapy for HIV be started?

Authors:  Andrew N Phillips; Brian G Gazzard; Nathan Clumeck; Marcelo H Losso; Jens D Lundgren
Journal:  BMJ       Date:  2007-01-13

Review 6.  Time to move towards opt-out testing for HIV in the UK.

Authors:  M Hamill; K Burgoine; F Farrell; J Hemelaar; G Patel; D E Welchew; H W Jaffe
Journal:  BMJ       Date:  2007-06-30

Review 7.  Twenty-five years of HIV management.

Authors:  A Jayasuriya; C Robertson; P S Allan
Journal:  J R Soc Med       Date:  2007-08       Impact factor: 5.344

Review 8.  Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Authors:  Vicki Oldfield; Greg L Plosker
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 9.  Tuberculosis and HIV co-infection: a practical therapeutic approach.

Authors:  Ronan A M Breen; Leonie Swaden; Jayne Ballinger; Marc C I Lipman
Journal:  Drugs       Date:  2006       Impact factor: 9.546

10.  Comparative evaluation of the automated Roche TaqMan real-time quantitative human immunodeficiency virus type 1 RNA PCR assay and the Roche AMPLICOR Version 1.5 conventional PCR assay.

Authors:  Anthony R Oliver; Spyridon F Pereira; Duncan A Clark
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.